Shionogi & Co., the maker of the Crestor anticholesterol pill, has agreed to buy Sciele Pharma Inc. of the U.S. for $1.4 billion, adding research, development and sales staff.
Shareholders of Atlanta-based Sciele Pharma will receive $31 a share, Osaka-based Shionogi said Monday. The company will also pay $325 million related to a convertible bond.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
We humbly apologize for the inconvenience.